Biological activity and structure–activity relationship of dehydrodieugenol B analogues against visceral leishmaniasis
Visceral leishmaniasis is a neglected protozoan disease with high mortality. Existing treatments exhibit a number of limitations, resulting in a significant challenge for public health, especially in developing countries in which the disease is endemic. With a limited pipeline of potential drugs in...
Main Authors: | Amaral, M, Asiki, H, Sear, CE, Singh, S, Pieper, P, Haugland, MM, Anderson, EA, Tempone, AG |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado em: |
Royal Society of Chemistry
2023
|
Registos relacionados
-
Synthesis and structure–activity relationship of dehydrodieugenol B neolignans against Trypanosoma cruzi
Por: Sear, CE, et al.
Publicado em: (2020) -
Synthesis and anti-parasitic activity of dehydrodieugenol B and analogues
Por: Sear, C
Publicado em: (2020) -
Dehydrodieugenol B derivatives as antiparasitic agents: synthesis and biological activity against Trypanosoma cruzi
Por: Ferreira, D, et al.
Publicado em: (2019) -
Transcriptional blood signatures for active and amphotericin B treated visceral leishmaniasis in India.
Por: Michaela Fakiola, et al.
Publicado em: (2019-08-01) -
Mediastinal Lymphadenopathy in Visceral Leishmaniasis
Por: Surinder Singh Rana, et al.
Publicado em: (2021-08-01)